There is "insufficient" evidence available to support the introduction a Meningitis B immunisation, Government-appointed experts have said.
The Joint Committee on Vaccination and Immunisation (JCVI) said the efficacy of the Bexsero vaccine "has not been established" and it is "high unlikely" to be cost-effective.
The vaccine was licensed by the European Medicines Agency at the start of the year.
More top news
A split in conditions for the coming few days
Relatives of Becky Watts have said her death was the "most undignified end to a beautiful life full of promise".
Some sunshine is breaking through the wintry weather as Spring arrives.